MIP Technologies will be present at Pittcon 2006 (Orlando, March 12-17) - where it will be making a major announcement - and Analytica 2006 (Munich, April 25-28).
MIP Technologies has several R+D contracts with customers in pharma/biotech, food and other industries.
For example, the company has been working with FeF Chemicals, a wholly-owned subsidiary of Novo Nordisk, and has an ongoing contract with the US Environmental Protection Agency (EPA) for the development of MIP based solid-phase extraction materials for the extraction of pyrethroid pesticide residues from composite dietary samples.
After a collaboration with the Centers for Disease Control and Prevention (CDC) in Atlanta, MIP Technologies now supplies CDC with analytical MIP based SPE products.
The company has also entered into several collaboration agreements with major corporations which are still confidential.
MIP Technologies is working at the boundary between chemistry and material science using innovative proprietary technology.
In addition to unique know-how and intellectual property, the company has developed a technology platform enabling a rapid and economic development of custom made separation phases with superior properties.
It was founded by researchers from the European Research Network, Mica (Molecular Imprinting in Chemical Analysis) and has a strategic relationship with Professor Borje Sellergren at the University of Dortmund for cutting-edge research.
MIP Technologies is located in Lund, Sweden, and has 17 employees.
The privately-held company is owned by Teknoseed, Malmohus Invest, Catella Healthcare Investment, founders and management.
The company completed a SEK 30million (euro 3.25million) financing round, with Catella Healthcare Investments as lead investor, in August 2005.
